SCHEMBL95393

SCHEMBL95393

Nc1nc(O)nc2n[nH]cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014919 0.79 PDPK1 (0.39) —
Oxypurinol SCHEMBL2077651 0.79 — —
SCHEMBL7635291 0.76 — —
SCHEMBL1952035 0.68 — —
SCHEMBL839587 0.65 — —
Hydrochloric Acid SCHEMBL1741651 0.65 PI4KA (0.44) —
Hydrochloric Acid SCHEMBL14742344 0.65 PI4KA (0.44) —
SCHEMBL95394 0.64 XDH (0.52) —
SCHEMBL5144478 0.64 ADORA2A (0.44) —
SCHEMBL19236510 0.63 CYP1A2 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3980554-B1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES HOFFMANN LA ROCHE (CH) 2025-03-26 — — EP claimed
US-20220195497-A1 HYBRIDIZING all-LNA OLIGONUCLEOTIDES ROCHE DIAGNOSTICS OPERATIONS, INC. 2022-06-23 — — US claimed
EP-3980554-A1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. Hoffmann-La Roche AG (CH) 2022-04-13 — — EP claimed
CN-113939599-A Hybrid all-LNA oligonucleotides 豪夫迈·罗氏有限公司 2022-01-14 — — CN claimed
WO-2020245377-A1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. HOFFMANN-LA ROCHE AG (CH) 2020-12-10 — — WO claimed
US-7829596-B2 Methods of treatment IMPERIAL INNOVATIONS LIMITED (GB) 2010-11-09 — — US claimed
US-20090023639-A1 Methods of Treatment IMPERIAL INNOVATIONS LIMITED (GB) 2009-01-22 — — US claimed
EP-0759298-B1 Use of 4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine for the manufacture of an antihypertensive agent MAEDA HIROSHI DR (JP) 2003-11-05 — — EP claimed
EP-0881875-A4 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELL PROP (US) 2002-03-06 — — EP claimed
US-6281222-B1 Compositions and method for treatment of acetaminophen intoxication INOTEK CORPORATION 2001-08-28 — — US claimed
WO-2000021509-A2 METHODS OF TREATMENT IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2000-04-20 — — WO claimed
US-6037344-A COMPRISING A PURINE SELECTED FROM THE GROUP CONSISTING OF XANTHINE, HYPOXANTHINE, GUANINE AND MIXTURES THEREOF, AND A XANTHINE OXIDASE INHIBITOR SELECTED FROM THE GROUP CONSISTING OF ALLOPURINOL, OXYPURINOL, MERCAPTO-ALLOPURINOL, VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2000-03-14 — — US claimed
EP-0881875-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1998-12-09 — — EP claimed
WO-1997028686-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1997-08-14 — — WO claimed
EP-0759298-A2 Pyrazolopyrimidine derivates as antihypertensive agents Maeda, Hiroshi, Dr. (JP) 1997-02-26 — — EP claimed
EP-0515379-A4 ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES GLYCOMED INC (US) 1994-09-14 — — EP claimed
EP-0515379-A1 ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES GLYCOMED INCORPORATED (US) 1992-12-02 — — EP claimed
US-5094740-A TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES GLYCOMED, INC. (US) 1992-03-10 — — US claimed
WO-1991012275-A1 TWO-DIMENSIONAL ELECTROPHORETIC SEPARATION OF CARBOHYDRATES GLYCOMED INCORPORATED (US) 1991-08-22 — — WO claimed
WO-1991012276-A1 ELECTRO-BLOTTING OF ELECTROPHORETICALLY RESOLVED FLUORESCENT-LABELED SACCHARIDES AND DETECTION OF ACTIVE STRUCTURES WITH PROTEIN PROBES GLYCOMED INCORPORATED (US) 1991-08-22 — — WO claimed
Send feedback